The protein kinase C inhibitor H-7, inhibits antigen and IL-2-induced proliferation of murine T cell lines

Biochem Biophys Res Commun. 1987 Jun 15;145(2):666-72. doi: 10.1016/0006-291x(87)91016-3.

Abstract

Activation of protein kinase C has been shown to be involved in the activation pathway of many cell types. Recently, a number of investigations have suggested that protein kinase C plays an essential role in T lymphocyte activation. The recent synthesis of the protein kinase inhibitors, H-7 and HA1004, have now made possible a new approach for testing the relevance of protein kinase C in T cell activation and proliferation. We now report that the antigen-induced and interleukin-2-induced proliferation of murine T cell lines can be consistently inhibited by the protein kinase C inhibitor, H-7. HA1004, a somewhat more potent inhibitor of cyclic nucleotide-dependent protein kinases, but a significantly weaker inhibitor of protein kinase C than H-7, demonstrated no consistent inhibition of these T cell responses. These results represent a further demonstration that protein kinase C plays an essential role in the activation of T cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Animals
  • Cell Division / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Interleukin-2 / pharmacology*
  • Isoquinolines / pharmacology*
  • Lymphocyte Activation / drug effects*
  • Mice
  • Myelin Basic Protein / pharmacology*
  • Piperazines / pharmacology*
  • Protein Kinase C / antagonists & inhibitors*
  • Protein Kinase C / blood
  • Sulfonamides*
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / enzymology

Substances

  • Interleukin-2
  • Isoquinolines
  • Myelin Basic Protein
  • Piperazines
  • Sulfonamides
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • N-(2-guanidinoethyl)-5-isoquinolinesulfonamide
  • Protein Kinase C